COGT - Cogent Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$50.00
DETAILS
HIGH:
$60.00
LOW:
$35.00
MEDIAN:
$52.00
CONSENSUS:
$50.00
UPSIDE:
49.70%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,868,389 | $71.9M | 0.0% | -379,415 | DECREASED |
| Wood | 1,410,826 | $54.3M | 0.1% | +583,301 | INCREASED |
| Druckenmiller | 0 | $0 | -- | -2,214,470 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-19 | Robbins Andrew R | director, officer: President and CEO | G-Gift | 160,000 | -- | -- |
| 2026-04-01 | Ferrante Karen Jean | director | A-Award | 686 | $35.24 | $24K |
| 2026-03-31 | Fairmount Funds Management LLC | director | C-Conversion | 7,000,000 | -- | -- |
| 2026-03-31 | Fairmount Funds Management LLC | director | SELL | 7,000,000 | $34.66 | $242.6M |
| 2026-03-31 | Fairmount Funds Management LLC | director | C-Conversion | 28,000 | -- | -- |
| 2026-01-22 | Fairmount Funds Management LLC | director | SELL | 3,500,000 | $36.40 | $127.4M |
| 2026-01-01 | Ferrante Karen Jean | director | A-Award | 643 | $34.74 | $22K |
| 2025-12-26 | Sachs Jessica | officer: Chief Medical Officer | SELL | 82,642 | $38.70 | $3.2M |
| 2025-12-26 | Robinson John Edward | officer: Chief Scientific Officer | SELL | 90,000 | $38.74 | $3.5M |
| 2025-12-26 | Kearns Evan | officer: Chief Legal Officer | SELL | 65,000 | $38.70 | $2.5M |
| 2025-12-26 | Green John L. | officer: Chief Financial Officer | SELL | 77,000 | $38.68 | $3.0M |
| 2025-12-17 | Sachs Jessica | officer: Chief Medical Officer | A-Award | 65,000 | $39.45 | $2.6M |
| 2025-12-17 | Green John L. | officer: Chief Financial Officer | A-Award | 300,000 | -- | -- |
| 2025-12-17 | Sachs Jessica | officer: Chief Medical Officer | A-Award | 50,000 | -- | -- |
| 2025-12-17 | Robinson John Edward | officer: Chief Scientific Officer | F-InKind | 139,998 | $39.45 | $5.5M |
| 2025-12-17 | Kearns Evan | officer: Chief Legal Officer | A-Award | 40,000 | -- | -- |
| 2025-12-17 | Pinnow Cole | officer: Chief Commercial Officer | A-Award | 50,000 | -- | -- |
| 2025-12-17 | Green John L. | officer: Chief Financial Officer | F-InKind | 145,007 | $39.45 | $5.7M |
| 2025-12-17 | Green John L. | officer: Chief Financial Officer | A-Award | 65,000 | $39.45 | $2.6M |
| 2025-12-17 | Green John L. | officer: Chief Financial Officer | A-Award | 50,000 | -- | -- |
| 2025-12-17 | Pinnow Cole | officer: Chief Commercial Officer | A-Award | 65,000 | $39.45 | $2.6M |
| 2025-12-17 | Kearns Evan | officer: Chief Legal Officer | A-Award | 260,000 | -- | -- |
| 2025-12-17 | Robinson John Edward | officer: Chief Scientific Officer | A-Award | 65,000 | $39.45 | $2.6M |
| 2025-12-17 | Robinson John Edward | officer: Chief Scientific Officer | A-Award | 50,000 | -- | -- |
| 2025-12-17 | Robbins Andrew R | director, officer: President and CEO | A-Award | 840,000 | -- | -- |